AN Acton nurse, working on diabetes clinical trials, is on the look-out for patients to take part in a ground-breaking new procedure.

Known as REVITA, the novel technique targets cells in the upper intestine and aims to help treat type 2 diabetes by restoring the body’s ability to regulate blood sugar.

Christwishes Makahamadze, who works at University College Hospital, says: “Type 2 diabetes affects so many in the North London area, so I’m delighted UCLH is involved in the trial.

“It could result in long-term reduction in  patients’ blood-sugar levels, reducing the need for multiple pills and injections.”

Figures show there are 24,383 people in Ealing (7.37% of the population) diagnosed with diabetes, the highest of any London borough

READ MORE: Jobs where you need patience to save for a house!

READ MORE: Affordable homes to be built on Tube stations car parks

The Revita™ procedure is incision-free and takes around an hour to complete under anaesthesia. It involves passing a catheter through the mouth down to the small intestine where a precisely-controlled heated balloon is activated to treat the lining of the duodenum.

The catheter and endoscope are removed at the end of the procedure, leaving no implant in the body.

Those who would like to take part in the trial should be 25-75 years old, have a Body Mass Index (BMI) between 24 and 40 and taking one or more oral diabetic medications (of which one should be Metformin) but not on injectable medications.

For more about the trial, visit www.RevitaTrial.com or email Christwishes on christwishes.makahamadze@nhs.net